<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhan C</submitter><funding>University of Hong Kong Seed Fund for PI Research - Translational and Applied Research</funding><funding>National Natural Science Foundation of China Young Scientists Fund</funding><pagination>e06438</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12561402</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(40)</volume><pubmed_abstract>Diabetes exacerbates the development and progression of periodontitis through the aggravation of persistent inflammation and tissue destruction. While the impact of diabetes on peripheral sensory nerves is well-documented, little is known about the role of diabetic neuropathy in bone destruction in diabetes-associated periodontitis. Herein, a significant loss of periodontal nerves is observed in the diabetic state of db/db mice, with trigeminal ganglion neurons showing decreased autophagy. These mice exhibit decreased density of calcitonin gene-related peptide (CGRP)&lt;sup>+&lt;/sup> nerves, correlating with the progression of diabetes and inflammatory state. Furthermore, diabetic mice with periodontitis show greater alveolar bone loss, which can be phenocopied by periodontal denervation. Importantly, CGRP receptor-related components are found to be expressed in periodontal endothelial cells. In both diabetic and denervated periodontium, the loss of CGRP signaling is associated with the reduction of type H vessel density and coupled osterix&lt;sup>+&lt;/sup> osteoprogenitors. To elaborate further, an injectable reactive oxygen species-responsive poly(vinyl alcohol) (PVA)/tsPBA hydrogel is developed for sustained CGRP delivery. Notably, the CGRP-loaded hydrogels promote alveolar bone regeneration via inducing type H vessel formation in diabetic mice. The findings highlight that diabetes-induced sensory nerve damage may exacerbate periodontitis-induced bone loss, and CGRP@PVA/tsPBA hydrogels offer a promising therapeutic strategy for bone regeneration.</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>CGRP-Loaded ROS-Responsive Hydrogel Restores Neuro-Angiogenic Signaling to Promote Bone Regeneration in Diabetes-Associated Periodontitis.</pubmed_title><pmcid>PMC12561402</pmcid><funding_grant_id>2403101930</funding_grant_id><funding_grant_id>2203100705</funding_grant_id><funding_grant_id>82401109</funding_grant_id><pubmed_authors>Tsoi JKH</pubmed_authors><pubmed_authors>Zhan C</pubmed_authors><pubmed_authors>Dai Q</pubmed_authors><pubmed_authors>Ren J</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Lin Y</pubmed_authors><pubmed_authors>Jin L</pubmed_authors><pubmed_authors>Ye Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>CGRP-Loaded ROS-Responsive Hydrogel Restores Neuro-Angiogenic Signaling to Promote Bone Regeneration in Diabetes-Associated Periodontitis.</name><description>Diabetes exacerbates the development and progression of periodontitis through the aggravation of persistent inflammation and tissue destruction. While the impact of diabetes on peripheral sensory nerves is well-documented, little is known about the role of diabetic neuropathy in bone destruction in diabetes-associated periodontitis. Herein, a significant loss of periodontal nerves is observed in the diabetic state of db/db mice, with trigeminal ganglion neurons showing decreased autophagy. These mice exhibit decreased density of calcitonin gene-related peptide (CGRP)&lt;sup>+&lt;/sup> nerves, correlating with the progression of diabetes and inflammatory state. Furthermore, diabetic mice with periodontitis show greater alveolar bone loss, which can be phenocopied by periodontal denervation. Importantly, CGRP receptor-related components are found to be expressed in periodontal endothelial cells. In both diabetic and denervated periodontium, the loss of CGRP signaling is associated with the reduction of type H vessel density and coupled osterix&lt;sup>+&lt;/sup> osteoprogenitors. To elaborate further, an injectable reactive oxygen species-responsive poly(vinyl alcohol) (PVA)/tsPBA hydrogel is developed for sustained CGRP delivery. Notably, the CGRP-loaded hydrogels promote alveolar bone regeneration via inducing type H vessel formation in diabetic mice. The findings highlight that diabetes-induced sensory nerve damage may exacerbate periodontitis-induced bone loss, and CGRP@PVA/tsPBA hydrogels offer a promising therapeutic strategy for bone regeneration.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T09:12:29.704Z</modification><creation>2026-05-15T03:12:23.572Z</creation></dates><accession>S-EPMC12561402</accession><cross_references><pubmed>40755317</pubmed><doi>10.1002/advs.202506438</doi></cross_references></HashMap>